Qiagen Net Income from 2010 to 2026
| QGEN Stock | USD 50.41 0.44 0.87% |
Net Income | First Reported 1996-03-31 | Previous Quarter 130 M | Current Value 107.8 M | Quarterly Volatility 48.1 M |
Check Qiagen NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Qiagen NV's main balance sheet or income statement drivers, such as Depreciation And Amortization of 103.4 M, Interest Expense of 31.6 M or Total Revenue of 1.1 B, as well as many indicators such as Price To Sales Ratio of 6.92, Dividend Yield of 0.0194 or PTB Ratio of 2.88. Qiagen financial statements analysis is a perfect complement when working with Qiagen NV Valuation or Volatility modules.
Qiagen | Net Income | Build AI portfolio with Qiagen Stock |
Evaluating Qiagen NV's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Qiagen NV's fundamental strength.
Latest Qiagen NV's Net Income Growth Pattern
Below is the plot of the Net Income of Qiagen NV over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Qiagen NV financial statement analysis. It represents the amount of money remaining after all of Qiagen NV operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Qiagen NV's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Qiagen NV's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 424.88 M | 10 Years Trend |
|
Net Income |
| Timeline |
Qiagen Net Income Regression Statistics
| Arithmetic Mean | 200,244,059 | |
| Coefficient Of Variation | 88.24 | |
| Mean Deviation | 153,628,311 | |
| Median | 129,506,000 | |
| Standard Deviation | 176,698,245 | |
| Sample Variance | 31222.3T | |
| Range | 554.1M | |
| R-Value | 0.69 | |
| Mean Square Error | 17650T | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | 23,989,711 | |
| Total Sum of Squares | 499556.3T |
Qiagen Net Income History
Other Fundumenentals of Qiagen NV
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Qiagen NV Net Income component correlations
About Qiagen NV Financial Statements
Qiagen NV investors utilize fundamental indicators, such as Net Income, to predict how Qiagen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income | 424.9 M | 446.1 M | |
| Net Income Applicable To Common Shares | 662 M | 695.1 M | |
| Net Income From Continuing Ops | 96.1 M | 91.3 M | |
| Net Income Per Share | 0.35 | 0.42 | |
| Net Income Per E B T | 0.87 | 0.62 |
Pair Trading with Qiagen NV
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qiagen NV position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qiagen NV will appreciate offsetting losses from the drop in the long position's value.Moving against Qiagen Stock
| 0.79 | GSS | Genetic Signatures Earnings Call This Week | PairCorr |
| 0.78 | OSL | Oncosil Medical Earnings Call This Week | PairCorr |
| 0.71 | CDT | Conduit Pharmaceuticals | PairCorr |
| 0.66 | HBIO | Harvard Bioscience | PairCorr |
| 0.52 | A | Agilent Technologies Earnings Call Tomorrow | PairCorr |
The ability to find closely correlated positions to Qiagen NV could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qiagen NV when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qiagen NV - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qiagen NV to buy it.
The correlation of Qiagen NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qiagen NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qiagen NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Qiagen NV can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Qiagen NV Correlation against competitors. To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Will Life Sciences Tools & Services sector continue expanding? Could Qiagen diversify its offerings? Factors like these will boost the valuation of Qiagen NV. Anticipated expansion of Qiagen directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Qiagen NV data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.219 | Dividend Share 0.263 | Earnings Share 2.04 | Revenue Per Share | Quarterly Revenue Growth 0.037 |
Investors evaluate Qiagen NV using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Qiagen NV's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Qiagen NV's market price to deviate significantly from intrinsic value.
It's important to distinguish between Qiagen NV's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Qiagen NV should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Qiagen NV's market price signifies the transaction level at which participants voluntarily complete trades.